Enter your email address
Submit
Write your message
Sun, Jul 3, 2022
[Archive]
Volume 7, Issue 3 (May & June 2022)
J Obstet Gynecol Cancer Res 2022, 7(3): 206-212 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Ayatollahi H, Jahangard S, Naji S, Yekta Z. Investigation of the P16 and Ki67 Predictive Effect on the Progression of Cervical Intraepithelial Neoplasia Grade 1 in Shahid Motahari Hospital of Urmia, Iran. J Obstet Gynecol Cancer Res. 2022; 7 (3) :206-212
URL: http://jogcr.com/article-1-491-en.html
URL: http://jogcr.com/article-1-491-en.html
1- Department of Obstetrics and Gynecology, School of Medicine, Solid Tumor Research Center, Research Institute on Cellular and Molecular Medicine, Shahid Motahari Hospital, Urmia University of Medical Sciences, Urmia, Iran
2- Department of Obstetrics and Gynecology, School of Medicine, Solid Tumor Research Center, Research Institute on Cellular and Molecular Medicine, Shahid Motahari Hospital, Urmia University of Medical Sciences, Urmia, Iran , samira_sjgh@yahoo.com
3- Department of Pathology, School of Medicine, Shahid Motahari Hospital, Urmia University of Medical Sciences, Urmia, Iran
4- Department of Community Medicine, School of Medicine, Reproductive Health Research Center, Urmia University of Medical Sciences, Urmia, Iran
2- Department of Obstetrics and Gynecology, School of Medicine, Solid Tumor Research Center, Research Institute on Cellular and Molecular Medicine, Shahid Motahari Hospital, Urmia University of Medical Sciences, Urmia, Iran , samira_sjgh@yahoo.com
3- Department of Pathology, School of Medicine, Shahid Motahari Hospital, Urmia University of Medical Sciences, Urmia, Iran
4- Department of Community Medicine, School of Medicine, Reproductive Health Research Center, Urmia University of Medical Sciences, Urmia, Iran
Abstract: (508 Views)
Background and Objective: Cervical cancer is a common neoplasm in women, and the role of the HPV virus in the development of precancerous and cancerous cells has been established. There exist different strains of the HPV virus with varied functions. In the high-risk HPV strains, the p16 and ki67 proteins play a crucial role in regulating the cell cycle leading to cell proliferation and progression. P16 and ki67 proteins are positive in almost all lesions and indicate a high degree of malignancy. This study aims to investigate the predictive effect of p16 and ki67 on the progression of low-grade intraepithelial lesions to high-grade malignancy.
Methods: P16 and ki67 were measured on CIN1 lesions, and during the average two-year follow-up period, the outcome of positive cases was investigated. A total of 106 referred patients between the age of 15 to 75 years were examined from April 2015 to March 2019.
Results: Among the patients with progression of CIN1 to CIN2 and other severe lesions, p16 was positive in 14 cases (60.9%), and a significant difference between groups with positive and negative markers in the progression or regression of lesions was noticed. Ki67 frequently occurs in CIN2 and other severe lesions.
Conclusion: The use of p16 and ki67 as predictive markers is still under debate. In countries like the United States, these are not yet used separately for prediction but are being used in combination together. The authors of this study strongly recommend the conduction of further studies to assess the role of p16 in association with other markers and within a larger population so as to apply the functional role of p16 and ki67 in the clinical setting thereby effectively preventing it.
Keywords: Uterine cervical cancer|P16|Ki67|HPV|CIN ,
Systematic Review: Original Research |
Subject:
Gynecology Oncology
Received: 2021/09/8 | Accepted: 2021/10/23 | Published: 2022/01/12
Received: 2021/09/8 | Accepted: 2021/10/23 | Published: 2022/01/12
References
1. Ahmed SA, Obaseki DE, Mayun AA, Mohammed A, Rafindadi AH, Abdul MA. The role of biomarkers (p16INK4a and Ki-67) in cervical cancer screening: An appraisal. Ann Trop Pathol. 2017;8(1):1. [DOI:10.4103/atp.atp_3_17]
2. Liu M, Yan X, Zhang M, Li X, Li S, Jing M. Influence of Human Papillomavirus Infection on the Natural History of Cervical Intraepithelial Neoplasia 1: A Meta-Analysis. BioMed Res Int. 2017;2017:8971059. [DOI:10.1155/2017/8971059] [PMID] [PMCID]
3. Basu P, Taghavi K, Hu SY, Mogri S, Joshi S. Management of cervical premalignant lesions. Curr Probl Cancer. 2018;42(2):129-36. [DOI:10.1016/j.currproblcancer.2018.01.010] [PMID]
4. Mitra A, Tzafetas M, Lyons D, Fotopoulou C, Paraskevaidis E, Kyrgiou M. Cervical intraepithelial neoplasia: screening and management. Br J Hosp Med. 2016;77(8):C118-23. [DOI:10.12968/hmed.2016.77.8.C118] [PMID]
5. Schiffman MH, Bauer HM, Hoover RN, Glass AG, Cadell DM, Rush BB, et al. Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. JNCI: J Natl Cancer Inst. 1993;85(12):958-64. [DOI:10.1093/jnci/85.12.958] [PMID]
6. Muñoz N, Bosch FX, De Sanjosé S, Herrero R, Castellsagué X, Shah KV, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 2003;348(6):518-27. [DOI:10.1056/NEJMoa021641] [PMID]
7. da Costa LBE, Triglia RDM, França Junior MC, Andrade LALDA. p16 INK 4a expression as a potential marker of low‐grade cervical intraepithelial neoplasia progression. Apmis. 2015;123(3):185-9. [DOI:10.1111/apm.12338] [PMID]
8. Savone D, Carrone A, Riganelli L, Merlino L, Mancino P, Benedetti Panici P. Management of HPV-related cervical disease: role of p16INK4a immunochemistry. Review of the literature. Tumori. 2016;102(5):450-8. [DOI:10.5301/tj.5000524] [PMID]
9. Martin CM, O'Leary JJ. Histology of cervical intraepithelial neoplasia and the role of biomarkers. Best Pract Res Clin Obstet Gynaecol. 2011;25(5):605-15. [DOI:10.1016/j.bpobgyn.2011.04.005] [PMID]
10. Liu Y, Alqatari M, Sultan K, Ye F, Gao D, Sigel K, et al. Using p16 immunohistochemistry to classify morphologic cervical intraepithelial neoplasia 2: correlation of ambiguous staining patterns with HPV subtypes and clinical outcome. Human pathol. 2017;66:144-51. [DOI:10.1016/j.humpath.2017.06.014] [PMID] [PMCID]
11. Gonçalves JE, Andrade CVd, Russomano FB, Nuovo GJ, Amaro-Filho SM, Carvalho MO, et al. The role of p16 as putative biomarker for cervical neoplasia: A controversial issue. MedicalExpress. 2017;4(6). [DOI:10.5935/MedicalExpress.2017.06.01]
12. Sagasta A, Castillo P, Saco A, Torné A, Esteve R, Marimon L, et al. p16 staining has limited value in predicting the outcome of histological low-grade squamous intraepithelial lesions of the cervix. Modern Pathol. 2016;29(1):51. [DOI:10.1038/modpathol.2015.126] [PMID]
13. Tsoumpou I, Arbyn M, Kyrgiou M, Wentzensen N, Koliopoulos G, Martin-Hirsch P, et al. p16(INK4a) immunostaining in cytological and histological specimens from the uterine cervix: a systematic review and meta-analysis. Cancer Treat Rev. 2009;35(3):210-20. [DOI:10.1016/j.ctrv.2008.10.005] [PMID] [PMCID]
14. Hebbar A, Murthy VS. Role of p16/INK4a and Ki-67 as specific biomarkers for cervical intraepithelial neoplasia: An institutional study. J Lab physicians. 2017;9(2):104. [DOI:10.4103/0974-2727.199630] [PMID] [PMCID]
15. Miyamoto S, Hasegawa J, Morioka M, Hirota Y, Kushima M, Sekizawa A. The association between p16 and Ki-67 immunohistostaining and the progression of cervical intraepithelial neoplasia grade 2. Int J Gynecol Obstet. 2016;134(1):45-8. [DOI:10.1016/j.ijgo.2015.12.005] [PMID]
16. Zhong P, Li J, Gu Y, Liu Y, Wang A, Sun Y, et al. P16 and Ki-67 expression improves the diagnostic accuracy of cervical lesions but not predict persistent high risk human papillomavirus infection with CIN1. Int J Clin Exp Pathol. 2015;8(3):2979.
17. Zhang X, Shen D. p16INK4a and Ki-67 measurement predict progression of cervical low-grade squamous intraepithelial lesion. Int J Clin Exp Pathol. 2018;11(8):4109-16.
18. Mills AM, Paquette C, Castle PE, Stoler MH. Risk stratification by p16 immunostaining of CIN1 biopsies. Am J Surg Pathol. 2015;39(5):611-7. [DOI:10.1097/PAS.0000000000000374] [PMID]
19. Pacchiarotti A, Ferrari F, Bellardini P, Chini F, Collina G, Dalla Palma P, et al. Prognostic value of p16‐INK4A protein in women with negative or CIN1 histology result: A follow‐up study. Int J Cancer. 2014;134(4):897-904. [DOI:10.1002/ijc.28407] [PMID]
20. Possati-Resende JC, Fregnani JH, Kerr LM, Mauad EC, Longatto-Filho A, Scapulatempo-Neto C. The Accuracy of p16/Ki-67 and HPV Test in the Detection of CIN2/3 in Women Diagnosed with ASC-US or LSIL. PloS one. 2015;10(7):e0134445. [DOI:10.1371/journal.pone.0134445] [PMID] [PMCID]
21. Chang HK, Seo S-S, Myong J-P, Yu YL, Byun SW. Incidence and costs of cervical intraepithelial neoplasia in the Korean population. J Gynecol Oncol. 2018;30(3). [DOI:10.3802/jgo.2019.30.e37] [PMID] [PMCID]
Send email to the article author
| Rights and permissions | |
 |
Journal of Obstetrics, Gynecology and Cancer Research by Farname Inc is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. Based on a work at http://jogcr.com/. |
Copyright Policy
Journal of Obstetrics, Gynecology and Cancer Research by Farname Inc is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Based on a work at http://jogcr.com/.
